Harold L Kim

Summary

Country: Canada

Publications

  1. ncbi Omalizumab: Practical considerations regarding the risk of anaphylaxis
    Harold L Kim
    University of Western Ontario, London, Ontario, Canada and McMaster University, Hamilton, Ontario, Canada
    Allergy Asthma Clin Immunol 6:32. 2010
  2. ncbi Skin prick testing in patients using beta-blockers: a retrospective analysis
    Irene N Fung
    McMaster University, Hamilton, Ontario, Canada
    Allergy Asthma Clin Immunol 6:2. 2010

Collaborators

  • Irene N Fung

Detail Information

Publications2

  1. ncbi Omalizumab: Practical considerations regarding the risk of anaphylaxis
    Harold L Kim
    University of Western Ontario, London, Ontario, Canada and McMaster University, Hamilton, Ontario, Canada
    Allergy Asthma Clin Immunol 6:32. 2010
    ....
  2. ncbi Skin prick testing in patients using beta-blockers: a retrospective analysis
    Irene N Fung
    McMaster University, Hamilton, Ontario, Canada
    Allergy Asthma Clin Immunol 6:2. 2010
    ..CONCLUSIONS: This data demonstrates the relative safety of administrating of skin prick tests to patients on beta-blocker treatment. Larger prospective studies are needed to substantiate the findings of this study...